Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MoonLake

BioTech Breakout: MoonLake Up 30% On FDA Wins

MoonLake shares are rallying after the FDA granted Fast Track designation for its lead drug and cleared the path for a major filing later this year.

Wolfspeed, Tilray, Robinhood, Etsy, And Moonlake Immunotherapeutics: Why These 5 Stocks Are On Investors' Radars Today

Wolfspeed, Tilray, Robinhood, Etsy, And Moonlake Immunotherapeutics: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks advanced today, with the Nasdaq climbing about 107 points, or 0.48%, to 22,591.15. The SP 500 added 0.26% to close at 6,661.21, while the Dow Jones Industrial Average edged up 0.15% to 46,316.07.

MoonLake Immunotherapeutics Stock Plummets After Phase 3 Data Readouts

MoonLake Immunotherapeutics Stock Plummets After Phase 3 Data Readouts

MoonLake Immunotherapeutics‘ (NASDAQ: MLTX) stock price fell off a cliff Monday after it reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday.

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

Organisations

Palantir Technologies

Las Vegas Sands

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

Dow Jones Industrial Average

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play